ADMA Biologics: Premium Valuation Justified By Strong Fundamentals And Future PotentialSeeking Alpha • 03/21/25
Wall Street Analysts Predict a 39.08% Upside in Adma Biologics (ADMA): Here's What You Should KnowZacks Investment Research • 03/21/25
Adma Biologics (ADMA) Surges 10.2%: Is This an Indication of Further Gains?Zacks Investment Research • 03/20/25
Should You Invest in Adma Biologics (ADMA) Based on Bullish Wall Street Views?Zacks Investment Research • 03/13/25
Adma Biologics (ADMA) Recently Broke Out Above the 50-Day Moving AverageZacks Investment Research • 03/12/25
Lost Money on ADMA Biologics, Inc.(ADMA)? You May Have Been Affected by Fraud- Contact Levi & KorsinskyAccesswire • 03/05/25
How Much Upside is Left in Adma Biologics (ADMA)? Wall Street Analysts Think 52.85%Zacks Investment Research • 03/05/25
BREAKING: Block & Leviton Investigating ADMA Biologics, Inc. for Securities Fraud Violations Following Delayed 10-K and KPMG Evaluation of ControlsGlobeNewsWire • 03/04/25
ADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateGlobeNewsWire • 03/03/25
ADMA Biologics to Participate in the Raymond James Institutional Investor ConferenceGlobeNewsWire • 02/28/25
Wall Street Analysts Look Bullish on Adma Biologics (ADMA): Should You Buy?Zacks Investment Research • 02/25/25
ADMA Biologics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025GlobeNewsWire • 02/25/25
Adma Biologics (ADMA) Advances But Underperforms Market: Key FactsZacks Investment Research • 02/06/25
ADMA Stock Catapults 275.7% in a Year: How Should You Play the Stock?Zacks Investment Research • 01/10/25
4 Drug, Biotech Stocks Rising More Than 50% in 2024 With Room to GrowZacks Investment Research • 12/24/24